David M. Holtzman

Chairman of the Department of Neurology at Washington University

David M. Holtzman

David M. Holtzman

Chairman of the Department of Neurology at Washington University

Overview
RelSci Relationships

3126

Number of Boards

7

Contact Data
Trying to get in touch with David M. Holtzman? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals David M. Holtzman likely has professional access to. A relationship does not necessarily indicate a personal connection.

Executive Vice Chancellor, Medical Affairs, George & Carol Bauer Dean at Washington University in St.Louis - School of Medicine

Relationship likelihood: Strong

Chair of Surgery/Director Siteman Cancer Center at Washington University

Relationship likelihood: Strong

Dean at Washington University in St. Louis - School of Arts & Sciences

Relationship likelihood: Strong

Chief Investment Officer at Washington University

Relationship likelihood: Strong

Dean, Olin Business School at Washington University

Relationship likelihood: Strong

Dean, Sam Fox School of Design & Visual Arts at Washington University

Relationship likelihood: Strong

Director-National Council at Washington University in St.Louis - School of Medicine

Relationship likelihood: Strong

Executive Director, Alzheimer's Disease Research Center at Washington University in St.Louis - School of Medicine

Relationship likelihood: Strong

Chairman, Department of Orthopedic Surgery at Washington University in St.Louis - School of Medicine

Relationship likelihood: Strong

Interim Chief Investment Officer at Washington University

Relationship likelihood: Strong

Paths to David M. Holtzman
Potential Connections via
Relationship Science
You
David M. Holtzman
Chairman of the Department of Neurology at Washington University
Career History
Chairman, Department of Neurology
Current

A leader in medical research, teaching and patient care, Washington University School of Medicine is currently ranked fourth in the nation by U.S. News & World Report. The School’s 2,100 employed and volunteer faculty physicians and clinicians -- known as Washington University Physicians -- are also medical staff members of Barnes-Jewish and St. Louis Children’s hospitals. The clinical practice group provides care to more than 430,000 children and adults at 49 clinical sites annually. Together, the institutions located on the Washington University Medical Center campus employ more than 21,000 clinicians, scientists, residents, fellows, administrators and support staff.

Professional
Current

DEVOTED TO ADVANCING THE GOALS OF ACADEMIC NEUROLOGY.

Chairman of the Department of Neurology
Current

The mission of Washington University in St. Louis is the promotion of learning — learning by students and by faculty. Teaching, the transmission of knowledge, is central to our mission, as is research, the creation of new knowledge. Faculty — composed of scholars, scientists, artists and members of the learned professions — serve society by teaching; by adding to the store of human art, creativity, understanding, and wisdom; and by providing direct services, such as health care. The university offers more than 90 programs and almost 1,500 courses leading to bachelor's, master's and doctoral degrees in a broad spectrum of traditional and interdisciplinary fields, with additional opportunities for minor concentrations and individualized programs.

Boards & Committees
Member, Scientific Resource Board
Current

Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer, Kenneth B. Lee and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.

Member, Scientific Advisory Board
Current

Proclara Biosciences, Inc. provides treatment of chronic neurodegenerative diseases. The firm develops therapies for protein misfolding diseases, such as chronic diseases of aging and certain orphan indications by harnessing General Amyloid Interaction Motif (GAIM), which is a multi-target approach that reduces levels of pathological misfolded protein deposits. The company was founded by Hampus Jacob Hillerstrom and Jonathan Eithan Solomon in December 2006 and is headquartered in Cambridge, MA.

Member, Scientific Advisory Board
Current

Denali Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates for neurodegenerative diseases. Its product pipeline includes LRRK2, RIPK1, TREM2, and Tau. The company was founded by Ryan J. Watts, Marc Tessier-Lavigne, and Alexander Schuth on October 14, 2013 and is headquartered in San Francisco, CA.

President, Board of Directors
Current

DEVOTED TO ADVANCING THE GOALS OF ACADEMIC NEUROLOGY.

Member, Medical Research Advisory Committee
Current

The JPB Foundation marks a new beginning in the enduring philanthropic legacy of Jeffry M. and Barbara Picower. Born to ordinary circumstance and educated as a lawyer, the late Jeffry M. Picower used his exceptional skill as an investor to pursue a lifetime of giving. Jeffry and Barbara measured their success not by accumulated wealth, but rather by their ability to make the world a better place, particularly for those who were unable to do so for themselves. For decades, Jeffry and Barbara gave extensively to an array of medical, youth, and civic causes, with the goal of helping to create a better world. Among numerous high-impact grants made through The Picower Foundation, Jeffry and Barbara gave early backing to the Harlem Children’s Zone and organized the Picower Quality Childcare Initiative, a multi-partner program to improve the quality of child care within Palm Beach County. Their 2002 grant of $50 million to the Massachusetts Institute of Technology, which created the Picower Institute for Learning and Memory, was then the largest donation the university had received from a private foundation.

Member, Alzheimer's Disease Research Committee
Current

BRIGHTFOCUS FOUNDATION (BRIGHTFOCUS) SEEKS A WORLD FREE FROM DISEASES OF MIND AND SIGHT.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by David M. Holtzman. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of David M. Holtzman's profile does not indicate a business or promotional relationship of any kind between RelSci and David M. Holtzman.